Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity Extends License with GlaxoSmithKline

NEW YORK (GenomeWeb News) – Ingenuity Systems announced today that it has extended and expanded its licensing agreement with GlaxoSmithKline providing the drug giant with access to Ingenuity Pathways Analysis software.
 
The new pact enables GSK to provide enterprise-wide IPA access to researchers assessing signaling and metabolic pathways, molecular networks, and biological processes that are most significant to disease targets. GSK also will use Ingenuity’s content and proprietary algorithms, the Redwood City, Calif.-based bioinformatics firm said in a statement.
 
Financial terms of the agreement were not disclosed.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.